Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
rilotumumab
×
Clear all
Filters
3
NCT02137343
2016-04-04
RILOMET-2
Amgen
Phase 3
Terminated
34 enrolled
NCT01697072
2016-02-09
RILOMET-1
Amgen
Phase 3
Terminated
609 enrolled